Cite
APA Citation
Gebrehiwet, P., Meng, L., Rudnicki, S. A., Sarocco, P., Wei, J., Wolff, A. A., Butzner, M., Chiò, A., Andrews, J. A., Genge, A., Hughes, D. A., Jackson, C. E., Lechtzin, N., Miller, T. M., & Shefner, J. M. (2023). health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS. Journal of medical economics, 26, 488–493. http://access.bl.uk/ark:/81055/vdc_100181752201.0x000020